ROSSI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 3.336
EU - Europa 2.490
AS - Asia 1.519
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 7
OC - Oceania 4
Totale 7.386
Nazione #
US - Stati Uniti d'America 3.286
CN - Cina 894
IE - Irlanda 569
SE - Svezia 501
SG - Singapore 454
FI - Finlandia 435
IT - Italia 308
UA - Ucraina 240
DE - Germania 228
TR - Turchia 117
FR - Francia 57
CA - Canada 46
GB - Regno Unito 36
BE - Belgio 33
AT - Austria 29
BR - Brasile 20
IN - India 20
CZ - Repubblica Ceca 18
ES - Italia 14
NL - Olanda 13
EU - Europa 9
VN - Vietnam 8
MY - Malesia 6
AU - Australia 4
MX - Messico 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CI - Costa d'Avorio 3
HK - Hong Kong 2
JP - Giappone 2
KZ - Kazakistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 7.386
Città #
Chandler 613
Dublin 567
Santa Clara 380
Singapore 365
Jacksonville 309
Ashburn 237
Dearborn 212
Beijing 173
Ann Arbor 161
Boardman 146
Nanjing 131
Izmir 104
Princeton 103
Parma 101
Shanghai 81
Wilmington 76
San Mateo 71
Helsinki 62
Nanchang 59
Shenyang 58
Toronto 41
Bremen 40
Seattle 35
Hebei 34
Brussels 32
Los Angeles 32
Woodbridge 32
Jinan 29
Guangzhou 26
Hefei 26
Jiaxing 26
Kunming 26
Vienna 26
Milan 25
Changsha 23
Tianjin 21
New York 20
Dallas 19
Des Moines 19
Brno 18
Falls Church 15
Norwalk 15
Fremont 13
Grafing 12
Munich 11
Bologna 10
Houston 10
Taizhou 10
Rome 9
Zhengzhou 9
Dong Ket 8
Padova 8
Pune 8
Borås 6
Guarapuava 6
Mestre 6
Rockville 6
Santiago De Compostela 6
Fairfield 5
Hangzhou 5
Marseille 5
Montegaldella 5
Ningbo 5
Washington 5
Wenzhou 5
Amsterdam 4
Ardea 4
Auburn Hills 4
Düsseldorf 4
Fuzhou 4
Konyaalti 4
London 4
Taiyuan 4
Uppsala 4
Wuhan 4
Xian 4
Abidjan 3
Bagnolo in Piano 3
Brooklyn 3
Chengdu 3
Formigine 3
Jerez de la Frontera 3
Kocaeli 3
Kyiv 3
Montréal 3
Naples 3
Philadelphia 3
Phoenix 3
Redwood City 3
Segrate 3
Timisoara 3
Vigo 3
Alcamo 2
Bari 2
Birmingham 2
Bolzano 2
Bonate Sopra 2
Boston 2
Brescia 2
Campli 2
Totale 4.870
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 150
Opportunity and challenges of nasal powders: Drug formulation and delivery 132
MULTILAYERED PHARMACEUTICAL FORMULATION 128
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 110
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 106
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 104
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 101
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 96
Thermal degradation and melting point determination of diclofenac 95
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 95
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 94
Aerodynamic performance of jet nebulizers marketed in Germany 93
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 92
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 89
Alginate containing formulations: are they all the same? 89
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 89
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 88
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 88
Thermal and Morfological characterisation of micronized acetylsalicylic acid powders prepared by rapid expansion of a supercritical solution 87
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 87
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 87
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 87
Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide 86
Interaction of pharmaceutical hydrates with supoercritical CO2: solubility, solid state and chemical modifications 86
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 86
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 85
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 84
Thermal Properties of Binary Mixtures of b-Cyclodextrin with Carbamazepine Polymorphs 84
Current status of ATP-ase proton pump inhibitor complexation with cyclodextrins 83
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 82
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 81
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 80
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 79
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 79
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 79
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 78
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 77
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 75
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 75
Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid 75
Development of solid lipid microparticles by melt-emulsification/spray-drying processes as carriers for pulmonary drug delivery 74
Hesperidin Gastroresistant Microparticles by Spray-Drying: Preparation, Characterization, and Dissolution Profiles 73
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 73
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 73
Le Basi del Calcolo Farmaceutico 72
Solid state characterization of paracetamol metastable polymorphs formed in binary mixtures with hydroxypropylmethylcellulose 71
Primary microparticles and agglomerates of morphine for nasal insufflation 69
Polymorphism of rac-5,6-Diisobutyryloxy-2-Methylamino-1,2,3,4-Tetrahydro-Napthalene Hydrochloride (CHF 1035). I. Thermal, Spectroscopic, and X-ray Diffraction Properties 69
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 69
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 69
High Respirable Insulin Dry Powder for Pulmonary Administration 68
New Farnesane Sesquiterpenes from Lactarius Porninsis 67
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 67
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 67
Layered lipid microcapsules for mesalazine delayed-release in children 66
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 65
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 65
Particles and powders: Tools of innovation for non-invasive drug administration 65
Pantoprazole Cyclodextrin Inclusion Complexes 64
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 64
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 64
Nasal Powders of Morphine Microcrystal Agglomerates 64
Swellable and rigid matrices: Controlled Release Matrices with Cellulose Ethers 64
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 64
New salt of cysteamine for the preparation of highly respirable particles 64
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 63
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 62
Polymorphism in Cocoa Butter Under Shear 62
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction 62
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 62
Lecithin/Chitosan Based Nanosystem for Tamoxifen Citrate Oral Delivery 62
Soft agglomerates of mesalazine multiparticles for colonic delivery in pediatric patients 61
Thermal behavior of paracetamol-polymeric excipients mixtures 61
Inclusion Properties, Polymorphism and Desolvation Kinetics in aNew 2-Pyridyl Iminophenol Compound with 1D Nanochannels 60
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 60
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 59
Multi-kinetics and site-specific oral delivery system of artemether and clindamycin for malaria theraphy 56
In vitro comparison of medicinal products based on alginic acid claimed to protect the esophagus wall and physically prevent acid reflux 56
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 55
Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles 55
Influence of tamoxifen citrate loading on lecithin/chitosan nanoparticles 54
Phase diagrams in the binary system 54
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 54
New Protoilludane Sesquiterpenes from Lactarius Violascens” 51
Nasal Powders of Morphine Microcrystal Agglomerates 51
Understanding and enhancing density distribution inside tableted Dome Matrix modules 51
Quercetin Microspheres by Solvent Evaporation: Preparation, Characterization and Release Behavior 50
New Farnesane Sesquiterpenes from Lactarius Porninsis 50
PREPARATION OF SOFT AGGLOMERATES BASED ON ARTEMISININ-βCD COMPLEXES 50
In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery 50
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 50
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 50
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 49
Innovative technologies for oral drug delivery 47
Soft agglomerates of pantoprazole gastro-resistant microparticles for oral administration and intestinal release 47
Conversion of carbamazepine polymorphs in supercritical CO2 45
The Development of Insulin Dry Powder Blends for Pulmonary Administration 45
In Situ Small Angle X-ray Scattering (SAXS) Studies of Polymorphism with the Associated Crystallization of Cocoa Butter Fat Using Shearing Conditions 44
Insulin spray-dried powder and smoothed lactose: a new formulation strategy for nasal and pulmonary delivery 43
Preparation and Characterization of a Pantoprazole New Drug Delivery System for Oral Administration Based on Soft Agglomerates 41
Totale 7.203
Categoria #
all - tutte 28.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020608 0 0 0 0 0 172 160 32 83 63 21 77
2020/2021592 8 59 53 13 82 17 81 22 131 23 85 18
2021/2022603 11 13 11 28 25 25 78 89 27 42 47 207
2022/20232.160 222 246 146 167 189 236 20 142 706 19 52 15
2023/2024810 34 88 24 55 67 191 65 47 26 47 69 97
2024/20251.139 74 133 146 163 285 338 0 0 0 0 0 0
Totale 7.530